Financière de Tubize S.A.
TUB
Classificação em ações
#2220
Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a... Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a global biopharmaceutical firm, primarily through its investment in UCB. The company is dedicated to discovering and advancing innovative medicines and solutions focused on neurological and immunological disorders. Its current commercial offerings include Cimzia, an established treatment for a range of inflammatory conditions such as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis. For partial-onset seizures in epilepsy, it provides Briviact, Vimpat, and Keppra, alongside Nayzilam, a nasal spray. Neupro addresses Parkinson's disease and restless legs syndrome. Additionally, the portfolio features Evenity, an injectable therapy for osteoporosis, and Bimzelx, used to manage moderate to severe plaque psoriasis. The company's development pipeline highlights several promising candidates: Staccato, aimed at stereotypical prolonged seizures; Bepranemab for Alzheimer's disease; and UCB0599 for Parkinson's disease. Other therapies under investigation include bimekizumab, which targets psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab, for conditions like myasthenia gravis, immune thrombocytopenia, myelin oligodendrocyte glycoprotein antibody disease, and autoimmune encephalitis; and dapirolizumab pegol, intended for systemic lupus erythematosus.
Preço da ação
$203.04
Valor de mercado
$9.04B
Variação (1 dia)
-7.47%
Variação (1 ano)
-25.36%
País
BE
Negociar Financière de Tubize S.A. (TUB)
Categoria
Healthcare
Rácio P/B de Financière de Tubize S.A. (TUB)
Rácio P/B em October 2026 TTM: 3.88
De acordo com os relatórios financeiros mais recentes e o preço das ações da Financière de Tubize S.A., o rácio P/B atual (TTM) é 3.88. No final de 2023, o rácio P/B era 1.78.
Histórico do rácio P/B da Financière de Tubize S.A. de 2003 a 2026
Rácio P/B no final de cada ano
| Ano | Rácio P/B | Alterar |
|---|---|---|
| 2026 (TTM) | 3.88 | 12.83% |
| 2024 | 3.44 | 93.61% |
| 2023 | 1.78 | -1.27% |
| 2022 | 1.80 | 45.33% |
| 2021 | 1.24 | -5.96% |
| 2020 | 1.32 | 23.95% |
| 2019 | 1.06 | -8.04% |
| 2018 | 1.15 | -16.50% |
| 2017 | 1.38 | 2.53% |
| 2016 | 1.35 | -13.33% |
| 2015 | 1.56 | 7.29% |
| 2014 | 1.45 | 7.13% |
| 2013 | 1.35 | 40.45% |
| 2012 | 0.96 | 37.78% |
| 2011 | 0.70 | 3.15% |
| 2010 | 0.68 | -15.07% |
| 2009 | 0.80 | 63.65% |
| 2008 | 0.49 | -56.17% |
| 2007 | 1.11 | -37.19% |
| 2006 | 1.77 | -9.56% |
| 2005 | 1.96 | -22.63% |
| 2004 | 2.53 | -19.22% |
| 2003 | 3.14 | 0.00% |
Rácio P/B de empresas semelhantes ou concorrentes
| Empresa | Rácio P/B | Diferença do rácio P/B | País |
|---|---|---|---|
| 6.251 | 61.05% |
US
|
|
| 13.2547 | 241.50% |
US
|
|
| 4.208 | 8.42% |
AU
|
|
| 6.1824 | 59.29% |
NL
|
|
| - | - |
CH
|
